Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

3.85
Delayed Data
As of 3:59pm ET
 -0.20 / -4.94%
Today’s Change
3.50
Today|||52-Week Range
7.57
-24.51%
Year-to-Date
No recent news for Compugen Ltd.

Today’s Trading

Previous close4.05
Today’s open4.00
Day’s range3.85 - 4.05
Volume83,116
Average volume (3 months)128,914
Market cap$207.1M
Dividend yield--
Data as of 3:59pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)-55.00%
Earnings growth (this year)-10.48%
Earnings growth (next 5 years)--
Revenue growth (last year)-92.33%
P/E ratioNM
Price/Sales364.28
Price/Book3.26

Competitors

 Today’s
change
Today’s
% change
PIRSPieris Pharmaceutica...-0.06-1.25%
PTGXProtagonist Therapeu...-0.88-7.33%
KDMNKadmon Holdings Inc-0.08-2.15%
KMDAKamada Ltd-0.23-3.66%
Data as of 4:02pm ET, 06/27/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$712.0K
Annual profit (last year)-$31.5M
Net profit margin-4,425.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Anat Cohen-Dayag
Chief Operating &
Financial Officer
Ari Krashin
Corporate headquarters
Holon, Tel Aviv

Forecasts